L.G. Cavallaro

1.6k total citations
34 papers, 1.2k citations indexed

About

L.G. Cavallaro is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L.G. Cavallaro has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 15 papers in Gastroenterology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L.G. Cavallaro's work include Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (14 papers) and Gastrointestinal motility and disorders (8 papers). L.G. Cavallaro is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (15 papers), Gastroesophageal reflux and treatments (14 papers) and Gastrointestinal motility and disorders (8 papers). L.G. Cavallaro collaborates with scholars based in Italy, United States and France. L.G. Cavallaro's co-authors include Francesco Di Mario, Giulia Martina Cavestro, A. Franzè, Vlad Ratziu, Luminita Bonyhay, Frédéric Charlotte, Philippe Giral, André Grimaldi, Vincent Di Martino and P Opolon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

L.G. Cavallaro

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.G. Cavallaro Italy 17 705 378 244 179 163 34 1.2k
Anton Gillessen Germany 14 260 0.4× 151 0.4× 132 0.5× 73 0.4× 221 1.4× 50 905
Enver Dolar Türkiye 15 279 0.4× 476 1.3× 53 0.2× 189 1.1× 66 0.4× 53 943
Sadakat Özdil Türkiye 18 296 0.4× 244 0.6× 88 0.4× 179 1.0× 38 0.2× 37 714
Yasuhiko Maruyama Japan 15 405 0.6× 343 0.9× 171 0.7× 46 0.3× 121 0.7× 40 1.2k
Gab Jin Cheon South Korea 18 301 0.4× 476 1.3× 104 0.4× 423 2.4× 158 1.0× 88 1.2k
Nicola Caporaso Italy 15 304 0.4× 611 1.6× 63 0.3× 75 0.4× 32 0.2× 21 977
Ramón Bartolí Spain 16 365 0.5× 570 1.5× 75 0.3× 528 2.9× 68 0.4× 38 1.2k
Orhan Kürşat Poyrazoğlu Türkiye 15 178 0.3× 338 0.9× 39 0.2× 179 1.0× 86 0.5× 33 731
John J. Fromkes United States 21 490 0.7× 215 0.6× 113 0.5× 89 0.5× 217 1.3× 30 939
C.‐H. Florén Sweden 18 429 0.6× 296 0.8× 108 0.4× 97 0.5× 121 0.7× 47 996

Countries citing papers authored by L.G. Cavallaro

Since Specialization
Citations

This map shows the geographic impact of L.G. Cavallaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.G. Cavallaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.G. Cavallaro more than expected).

Fields of papers citing papers by L.G. Cavallaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.G. Cavallaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.G. Cavallaro. The network helps show where L.G. Cavallaro may publish in the future.

Co-authorship network of co-authors of L.G. Cavallaro

This figure shows the co-authorship network connecting the top 25 collaborators of L.G. Cavallaro. A scholar is included among the top collaborators of L.G. Cavallaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.G. Cavallaro. L.G. Cavallaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavallaro, L.G., Fabio Monica, Bastianello Germanà, et al.. (2013). Time trends and outcome of gastrointestinal bleeding in the Veneto Region: A retrospective population based study from 2001 to 2010. Digestive and Liver Disease. 46(4). 313–317. 25 indexed citations
2.
Gatta, Luigi, D. Vaira, Carmelo Scarpignato, et al.. (2010). P.26 DIAGNOSTIC ACCURACY OF SERUM PEPSINOGENS AND GASTRIN IN THE FOLLOW-UP OF HELICOBACTER PYLORI INFECTION: A PILOT STUDY. Digestive and Liver Disease. 42. S112–S112. 1 indexed citations
3.
Guida, Laura, Massimo Caputo, Annarita Ianniello, et al.. (2009). INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE. Digestive and Liver Disease. 41. S83–S83.
4.
Guida, Laura, L.G. Cavallaro, Raffaella Alessia Zuppardo, et al.. (2008). PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD). Digestive and Liver Disease. 40. S77–S78.
5.
Nouvenne, Antonio, L.G. Cavallaro, Laura Martelli, et al.. (2008). W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor?. Gastroenterology. 134(4). A–629. 1 indexed citations
6.
Angelis, Gian Luigi De’, L.G. Cavallaro, Ali Mahamat Moussa, et al.. (2007). Usefulness of a Serological Panel Test in the Assessment of Gastritis in Symptomatic Children. Digestive Diseases. 25(3). 206–213. 24 indexed citations
7.
Comparato, Giuseppe, L. Fanigliulo, Giovanni Aragona, et al.. (2007). Quality of Life in Uncomplicated Symptomatic Diverticular Disease: Is It Another Good Reason for Treatment?. Digestive Diseases. 25(3). 252–259. 71 indexed citations
8.
Mario, Francesco Di, L.G. Cavallaro, & Carmelo Scarpignato. (2006). ‘Rescue’ Therapies for the Management of <i>Helicobacter pylori </i>Infection. Digestive Diseases. 24(1-2). 113–130. 50 indexed citations
9.
Mario, Francesco Di, L.G. Cavallaro, Giulia Martina Cavestro, & A. Franzè. (2006). Are there useful biomarkers for gastric cancer?. Digestive and Liver Disease. 38(5). 308–309. 7 indexed citations
10.
Cavallaro, L.G., Brian Egan, Colm O’Morain, & Francesco Di Mario. (2006). Treatment of Helicobacter pylori Infection. Helicobacter. 11(s1). 36–39. 20 indexed citations
11.
Fanigliulo, L., Giuseppe Comparato, Giovanni Aragona, et al.. (2006). Role of gut microflora and probiotic effects in the irritable bowel syndrome.. PubMed. 77(2). 85–9. 27 indexed citations
12.
Mario, Francesco Di, Giuseppe Comparato, L. Fanigliulo, et al.. (2006). Use of Mesalazine in Diverticular Disease. Journal of Clinical Gastroenterology. 40(Supplement 3). S155–S159. 27 indexed citations
13.
Mario, Francesco Di, L.G. Cavallaro, Ali Mahamat Moussa, et al.. (2006). Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium. Digestive Diseases and Sciences. 51(10). 1791–1795. 46 indexed citations
14.
Germanà, B., Francesco Di Mario, L.G. Cavallaro, et al.. (2005). Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Digestive and Liver Disease. 37(7). 501–508. 60 indexed citations
15.
Mario, Francesco Di, Anna Ingegnoli, L.G. Cavallaro, et al.. (2005). Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels. Fundamental and Clinical Pharmacology. 19(4). 497–501. 24 indexed citations
16.
Mario, Francesco Di, Giovanni Aragona, Gioacchino Leandro, et al.. (2005). Efficacy of Mesalazine in the Treatment of Symptomatic Diverticular Disease. Digestive Diseases and Sciences. 50(3). 581–586. 82 indexed citations
17.
Mario, Francesco Di, Nadia Dal Bó, Massimo Rugge, et al.. (2005). Natural Course of Functional Dyspepsia After Helicobacter pyloriEradication: A Seven-Year Survey. Digestive Diseases and Sciences. 50(12). 2286–2295. 16 indexed citations
18.
Mario, Francesco Di, Ali Mahamat Moussa, Nadia Dal Bó, et al.. (2005). Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4‐year study. Journal of Gastroenterology and Hepatology. 20(11). 1661–1666. 9 indexed citations
19.
Mario, Francesco Di, Ali Mahamat Moussa, L.G. Cavallaro, et al.. (2004). Clinical Usefulness of Serum Pepsinogen II in the Management of <i>Helicobacter pylori</i> Infection. Digestion. 70(3). 167–172. 21 indexed citations
20.
Ratziu, Vlad, Luminita Bonyhay, Vincent Di Martino, et al.. (2002). Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 35(6). 1485–1493. 369 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton Gillessen Breakdown of academic impact, for papers by Enver Dolar Breakdown of academic impact, for papers by Sadakat Özdil Breakdown of academic impact, for papers by Yasuhiko Maruyama Breakdown of academic impact, for papers by Gab Jin Cheon Breakdown of academic impact, for papers by Nicola Caporaso Breakdown of academic impact, for papers by Ramón Bartolí Breakdown of academic impact, for papers by Orhan Kürşat Poyrazoğlu Breakdown of academic impact, for papers by John J. Fromkes Breakdown of academic impact, for papers by C.‐H. Florén
Rankless by CCL
2026